- 专利标题: Mesostigmata mite control agent
-
申请号: US17845012申请日: 2022-06-21
-
公开(公告)号: US12108761B2公开(公告)日: 2024-10-08
- 发明人: Satoshi Nakamura , Takehiko Inoue , Haruka Takeuchi
- 申请人: MEIJI SEIKA PHARMA CO., LTD.
- 申请人地址: JP Tokyo
- 专利权人: MEIJI SEIKA PHARMA CO., LTD.
- 当前专利权人: MEIJI SEIKA PHARMA CO., LTD.
- 当前专利权人地址: JP Tokyo
- 代理机构: Sughrue Mion, PLLC
- 优先权: JP 17052200 2017.03.17
- 分案原申请号: US16494571
- 主分类号: A01N43/42
- IPC分类号: A01N43/42 ; A01P7/04
摘要:
A control agent comprising, as an active ingredient, a specific quinoline derivative compound such as 8-fluoro-2,3-dimethyl-6-(1,1-dimethylethyl)-4-(methylcarbonyl)oxyquinoline, azoxystrobin, picoxystrobin, pyraclostrobin, kresoxim-methyl, trifloxystrobin, metominostrobin, orysastrobin, famoxadone, fluoxastrobin, pyribencarb, cyazofamid, amisulbrom, flutolanil, mepronil, isofetamid, fluopyram, carboxin, thifluzamide, fluxapyroxad, furametpyr, penflufen, penthiopyrad, boscalid, diflumetorim, fluazinam, ferimzone, fenpyroximate, or an acid addition salt of any of these compounds shows an excellent controlling effect on Mesostigmata mites.
公开/授权文献
- US20220312766A1 MESOSTIGMATA MITE CONTROL AGENT 公开/授权日:2022-10-06
信息查询
IPC分类: